US13089P5070 - Common Stock
CALITHERA BIOSCIENCES INC
NASDAQ:CALA (2/1/2023, 7:04:28 PM)
After market: 0.3401 -0.02 (-6.85%)0.3651
-0.04 (-10.95%)
Calithera Biosciences, Inc. is a clinical-stage biopharmaceutical company, which focuses on discovering and developing small molecule drugs that target novel and critical metabolic pathways in tumor and cancer-fighting immune cells. The company is headquartered in South San Francisco, California and currently employs 63 full-time employees. The company went IPO on 2014-10-02. The firm is engaged in developing targeted therapies to redefine treatment for biomarker-specific patient populations. The firm is advancing a robust pipeline of investigational, small molecule oncology compounds with a biomarker-driven approach that targets genetic vulnerabilities in cancer cells to deliver new therapies for patients suffering from aggressive hematologic and solid tumor cancers. The firm is opportunistically developing therapeutics outside of oncology to treat diseases with unmet needs, as is the case in cystic fibrosis. The firm's Mivavotinib is a spleen tyrosine kinase (SYK) inhibitor, which targets the constitutively activated B-cell receptor (BCR) pathway in DLBCL and other non-Hodgkin lymphomas NHLs). Its Sapanisertib is a dual target of rapamycin kinase C I/II (TORC1/2) inhibitor that targets a key survival mechanism in KEAP1/NRF2-mutated tumor cells.
CALITHERA BIOSCIENCES INC
343 Oyster Point Blvd #200
South San Francisco CALIFORNIA 94080
P: 16508701000.0
CEO: Susan M. Molineaux
Employees: 63
Website: http://www.calithera.com/
Cancels Special Meeting of Stockholders...
Special Meeting to be Held on or about June 29, 2023 with a Record Date of May 25, 2023...
It's time to start off the day with an overview of the biggest pre-market stock movers traders need to know about on Wednesday!
We're starting off the day with an overview of the biggest pre-market stock movers traders need to know about for Tuesday!
Here you can normally see the latest stock twits on CALA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: